Literature DB >> 32356247

Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.

Yoshihiro Noguchi1, Tomoya Tachi2, Hitomi Teramachi3,4.   

Abstract

PURPOSE: Adverse events (AEs) caused by polypharmacy have recently become a clinical problem, and it is important to monitor the safety profile of drug-drug interactions (DDIs). Mining signals using the spontaneous reporting systems is a very effective method for single drug-induced AE monitoring as well as early detection of DDIs. The objective of this study was to compare signal detection algorithms for DDIs based on frequency statistical models.
METHODS: Five frequency statistical models: the Ω shrinkage measure, additive (risk difference), multiplicative (risk ratio), combination risk ratio, and chi-square statistics models were compared using the Japanese Adverse Drug Event Report (JADER) database as the spontaneous reporting system in Japan. The drugs targeted for the survey are all registered and classified as "suspect drugs" in JADER, and the AEs targeted for this study were the same as those in a previous study on Stevens-Johnson syndrome (SJS).
RESULTS: Of 3924 pairs that reported SJS, the number of signals detected by the Ω shrinkage measure, additive, multiplicative, combination risk ratio, and chi-square statistics models was 712, 3298, 2252, 739, and 1289 pairs, respectively. Among the five models, the Ω shrinkage measure model showed the most conservative signal detection tendency.
CONCLUSION: Specifically, caution should be exercised when the number of reports is low because results differ depending on the statistical models. This study will contribute to the selection of appropriate statistical models to detect signals of potential DDIs.

Entities:  

Keywords:  data mining algorithms; drug-drug interaction; frequency statistical model; signal detection; spontaneous reporting systems

Year:  2020        PMID: 32356247     DOI: 10.1007/s11095-020-02801-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".

Authors:  Yoshihiro Noguchi
Journal:  Drug Saf       Date:  2022-10-12       Impact factor: 5.228

2.  Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".

Authors:  Yoshihiro Noguchi
Journal:  Drug Saf       Date:  2022-06-17       Impact factor: 5.228

3.  Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio.

Authors:  Yoshihiro Noguchi; Keisuke Aoyama; Satoaki Kubo; Tomoya Tachi; Hitomi Teramachi
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-23

4.  Peripheral Neuropathy During Concomitant Administration of Proteasome Inhibitors and Factor Xa Inhibitors: Identifying the Likelihood of Drug-Drug Interactions.

Authors:  Long Meng; Jing Huang; Feng Qiu; Xuefeng Shan; Lin Chen; Shusen Sun; Yuwei Wang; Junqing Yang
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

5.  Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system.

Authors:  Eugene Jeong; Scott D Nelson; Yu Su; Bradley Malin; Lang Li; You Chen
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.